CLEARWATER, Fla., May 1, 2017 /PRNewswire/ -- Acacia Diversified Holdings, Inc. ("Acacia" or the "Company") (OTCQB symbol:ACCA), an emerging cannabis company, through its wholly owned subsidiaries, MariJ Pharmaceuticals, Inc. (MariJ) and Canna-Cures Research & Development Center, Inc. (Canna-Cures), focusing on the development of new and proprietary medicinal products
"We are very excited for our shareholders and future customers of Tennessee. Having ownership in a hemp license and being part of an exciting new pilot program manufacturing USDA organic hemp oils in Tennessee is quite an exciting time," said Richard K. Pertile, Acacia's Chief Executive Officer. "Taking steps to move more operations to the east coast is an efficient step for our Company. In addition to the Company working in a hemp pilot program in Tennessee, we are also waiting to hear about our opportunity to be awarded a low-THC, high-CBD, vertically integrated, grower's license in the state of Florida."
The Company has secured a $5,000,000.00 equity credit line with Peak One Opportunity Fund. Shareholders can review our latest financial filings, our annual report for the year ended December 31, 2016 on Form 10-K and our latest current report on Form 8-K, which is now publicly available for review on the OTC Markets trading platform and on the Company web site at: www.acaciadiversifiedholdings.com. The Company is current on all periodic report filings required by the Securities and Exchange Commission.
Forward-Looking StatementsStatements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/acacia-diversified-holdings-incs-subsidiary-awarded-the-hemp-pilot-program-license-in-tennessee-and-secures-financing-300448835.html
SOURCE Acacia Diversified Holdings, Inc.
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All